Loading
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (4 ops.)
Latest filing published 12 Aug 2026 for Axogen, Inc., €560k. Read the official filing
Filing timeline
BuySaleAmy McBride Wendell
Insider track record
Disclosed buys
2
Disclosed sells
4
Signal history
Closed purchases
Market purchases
2
Positive at T+90
100%
Median T+90
+41.8%
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +35.1%Entry US$66.12 · Close 29 Sept 2026 US$89.32
- +112.2%Entry US$6.55 · Close at T+365 US$13.90
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Amy McBride Wendell: trading record in brief
This profile gathers the share dealings of Amy McBride Wendell across 4 companies, led by Axogen, Inc., Hologic Inc and Baxter International Inc. The record holds 30 filings, for trades running from 4 May 2021 to 11 August 2026.
In open-market terms, that means 2 purchases worth €144k on one side and 4 sales worth €753k on the other. Taken together, the sales exceed the purchases by €609k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 11 share grants and 12 option exercises. 2026 to date brings 1 purchase and 2 sales.
Most recently, on 12 August 2026, the filings show an open-market sale worth €560k in Axogen, Inc. The last insider purchase was made public on 11 March 2026, 221 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Amy McBride Wendell
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations30 total
13,353 shares@ US$48.4230.025% mcap44.7% of flowCommon StockSEC:0000805928-26-000098:1
13,353 shares@ US$14.850.0077% mcap13.7% of flowCommon StockSEC:0000805928-26-000098:0
14,150 sharesCommon StockSEC:0001400568-26-000013:0
1,647 shares@ US$14.850.0009% mcap1.7% of flowCommon StockSEC:0001400568-26-000009:0
1,647 shares@ US$42.600.0027% mcap4.8% of flowCommon StockSEC:0001400568-26-000009:1
3,403 shares0Common StockSEC:0001400568-26-000007:0
25,784 sharesCommon StockSEC:0000859737-26-000077:0
1,980 shares0Common StockSEC:0001400568-26-000004:0
1,475 shares@ US$68.03100.0% of flowCommon StockSEC:0001400568-26-000002:0
Canonical exit: 8 Jun 2026 (T+90)
3,190 sharesCommon StockSEC:0000859737-26-000031:0
5,000 shares@ US$8.953.0% of flowCommon StockSEC:0001400568-25-000005:0
4,073 shares@ US$10.613.0% of flowCommon StockSEC:0000805928-25-000084:0
3,564 shares0Common StockSEC:0001628280-25-025956:0
7,183 shares0Common Stock, $1 par valueSEC:0001062993-25-008904:0
5,000 shares@ US$20.027.7% of flowCommon StockSEC:0000805928-25-000034:0
1,864 sharesCommon StockSEC:0001127602-25-007276:0
11,904 shares0Common StockSEC:0000805928-24-000114:0
10,653 sharesCommon StockSEC:0000805928-24-000103:0
5,952 shares0Common Stock, $1 par valueSEC:0001062993-24-009787:0
1,572 sharesCommon StockSEC:0001127602-24-009458:0
10,000 shares@ US$6.2244.6% of flowCommon StockSEC:0000805928-23-000124:0
Canonical exit: 5 Dec 2023 (T+90)
6,459 shares0Common StockSEC:0000805928-23-000060:0
25,000 shares@ US$9.2216.9% of flowCommon StockSEC:0000805928-23-000053:0
4,573 shares0Common Stock, $1 par valueSEC:0001062993-23-010216:0
1,465 sharesCommon StockSEC:0001127602-23-009879:0
25 of 30 declarations
